IVDA Iveda Solutions beats Q2 2024 EPS expectations by 412 percent but stock slips 067 percent in todays trading Great Elm GECCI Stock Should You Start a Position Great Elm posts 115 EPS miss vs market consensus Regeneron Pharmaceuticals REGN Otarmeni Gene Therapy Launch Shifts LongTerm Narrative Amid Pipeline Execution Focus NOW Inc PSENOW Valuation Assessment Amid Mixed Price Volatility and Consistent Overvaluation Signals BCAT BlackRockCap management outlines capital allocation plans and sector outlook in its latest quarterly earnings call GoPro GPRO Stock Is It Near Support Q4 2025 Earnings Underperform RILY BRC Group reports Q1 2024 EPS of negative 171 shares dip 131 with no prior analyst earnings estimates First Trust Natural Gas ETF FCG 2026 Performance Review and Investment Suitability Analysis